Wednesday, September 30, 2020

Was FDA Lax in Approving Opioids Too Easily?

pills and syringe on prescription

For at least two decades, the U.S. Food and Drug Administration has been approving new formulations of prescription opioids without requiring drug manufacturers to gather important information on safety and effectiveness, a new study claims.



from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_assets/site_images/article_thumbnails/slideshows/what_you_should_know_about_opioids_slideshow/650x350_what_you_should_know_about_opioids_slideshow.jpg https://ift.tt/30CDH9Z
via IFTTT

Related Posts:

  • Help Wanted: Volunteers for COVID Vaccine Trials Vaccine developers need thousands of people to take part in studies that will further test how well the vaccines work and how safe they are in much larger groups. from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/co… Read More
  • Alex Trebek Says Cancer Treatments 'Paying Off' He also announced he plans to return to the studio to film new episodes of his wildly popular game show in September. The show's filming has been in hiatus during the coronavirus pandemic. from WebMD Healthhttps://img.webm… Read More
  • Will CPR Save Your Life? Probably Not, Study Says Not only does the general public consider CPR more effective than it really is, they tend to discount the negative effect it can have, the researchers said. from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer… Read More
  • Another COVID Symptom Joins the List: Mouth Rash The rashes are clinically known as enanthem, and it's not surprising that they are showing up with COVID-19, said a U.S. dermatologist unconnected to the new study. from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/… Read More
  • RBG's Cancer Returns; She's Still Working In a statement from the Supreme Court, the 87-year-old senior member of the court's four-member liberal wing says she is able to do her job ''full steam." from WebMD Healthhttps://img.webmd.com/dtmcms/live/webmd/consumer_a… Read More

0 comments:

Post a Comment